Why I think this ASX penny stock is a bargain at its 52-week low

This health tech share hasn't been feeling the love from the market lately. But is there an upside on the horizon?

| More on:
A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The share price of ASX penny stock Mach7 Technologies Ltd (ASX: M7T) has plunged more than 30% in the past year.

Shares of the ASX health tech company closed on Friday at a new 52-week low of just 53 cents apiece. Long-term investors will be especially disappointed with the stock's continued poor performance. As recently as 2021, their shares were selling for over $1.50 a pop.

The market clearly wasn't impressed by the company's most recent financial results released last Wednesday. The company reported a net loss of $8 million for the year, and the Mach7 share price has dropped 12% since then.

But, if you take a closer look at the numbers, there are some hints that Mach7's new subscription-based business strategy could finally be starting to pay off.

If I'm right, Mach7 could soon be due for a rebound – which means its shares might be going for a bargain right now.

What does Mach7 do?

Mach7 develops medical imaging technology solutions for hospitals and other medical institutions, including universities and research facilities.

Its software integrates imaging data from different sources, providing doctors and other medical professionals with a central platform to view patient data. It connects different databases, standardises different data formats, and even helps healthcare providers interpret images to make diagnostic decisions.

The goal is to give doctors quick and easy access to the information they need to improve patient outcomes.

What's caused the drop in the Mach7 share price?

Over the past few years, Mach7 has been increasingly transitioning to a subscription-based business model.

Under this model, the revenue Mach7 earns per contract is actually higher, but it is delivered over the lifetime of the contract rather than upfront. This means that, as the company transitions, year-on-year revenues are likely to fall — at least until it starts making enough revenue from new subscriptions to offset the loss of upfront fees.

This was borne out in the company's most recent financial results. FY24 revenues were down 3% versus FY23, while the company's net loss increased a whopping 660% to almost $8 million.

But the interesting thing is that although its revenues were lower, Mach7 actually took in record numbers of new sales orders. It's just that 83% of them were subscription-based, versus 58% in FY23.

Mach7 points to these stats as evidence that its strategy is succeeding. However, many shareholders frustrated with the company's short-term financial performance are jumping ship, forcing the share price lower.

Why could Mach7 shares be a bargain right now?

The recurring revenues generated by a subscription-based model provide Mach7 – and its shareholders – with greater confidence about the company's future earnings. But, as we've explained, transitioning to this model can mean a hit to short-term revenues.

The good thing for Mach7 is that it seems to be nearing the end of its transition period. Just 6% of orders came from capital software sales in FY23, and recurring revenues increased 29% year-on-year to $21 million (out of total revenues of $29 million).

The company's outlook for FY25 is getting much rosier. It is targeting revenue growth of between 15% and 25%, which would be a significant turnaround versus this year's performance.

Delivering on these targets could restore investors' faith in the management over at Mach7 and quickly drive up its share price.

As with any penny stock, the risks from investing in Mach7 are high – but they might be worth it for growth-oriented investors.

Should you invest $1,000 in Mach7 Technologies Limited right now?

Before you buy Mach7 Technologies Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Mach7 Technologies Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor Rhys Brock has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Mach7 Technologies. The Motley Fool Australia has recommended Mach7 Technologies. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Lows

Investor looking at falling ASX share price on computer screen
Earnings Results

2 ASX All Ords shares crashing 16%+ on earnings updates

It's a red day for the market on Friday.

Read more »

Woman disappointed at share price performance with her hands on her face.
52-Week Lows

The Sayona Mining share price just hit a 4-year low

Things have gone form bad to worse for this lithium stock.

Read more »

Three people skydiving.
52-Week Lows

These ASX tech stocks just hit multi-year lows! Are they cheap?

A cheap share isn't always a bargain...

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Materials Shares

Ouch: The Pilbara Minerals share price just hit a multi-year low

It's been a tough day for lithium investors.

Read more »

A man holds his head as he looks at his laptop and contemplates more bills to pay.
Technology Shares

Guess which ASX 200 tech stock just crashed 13% on news from Microsoft?

The tech giant has dealt this company a blow. Let's see what is happening.

Read more »

Investor covering eyes in front of laptop
Materials Shares

Why are Syrah Resources shares crashing 32%?

This mining stock is being hammered again. What's going on?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Industrials Shares

This ASX share is tumbling 13% on reduced earnings forecast

Earnings are expected to fall in the first half, much to the dismay of the market.

Read more »

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
52-Week Lows

Down 68% from highs, this ASX 200 stock just hit a 4-year low. Time to pounce?

Is this beaten down stock a buy? Let's see what one leading broker is saying.

Read more »